These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26560497)

  • 21. S-Adenosylmethionine revisited: its essential role in the regulation of liver function.
    Avila MA; García-Trevijano ER; Martínez-Chantar ML; Latasa MU; Pérez-Mato I; Martínez-Cruz LA; del Pino MM; Corrales FJ; Mato JM
    Alcohol; 2002 Jul; 27(3):163-7. PubMed ID: 12163144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Latent alcoholic hepatopathy: diagnostic criteria, prognostic evaluation and therapeutic guidelines].
    Mancinella A
    Clin Ter; 1980 Mar; 92(5):549-60. PubMed ID: 6160943
    [No Abstract]   [Full Text] [Related]  

  • 23. [Parenteral S-adenosylmethionine compared to placebos in the treatment of alcoholic liver diseases].
    Diaz Belmont A; Dominguez Henkel R; Uribe Ancira F
    An Med Interna; 1996 Jan; 13(1):9-15. PubMed ID: 8679834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Affective illness and S-adenosyl methionine: a preliminary report.
    Carney MW; Edeh J; Bottiglieri T; Reynolds EM; Toone BK
    Clin Neuropharmacol; 1986; 9(4):379-85. PubMed ID: 2425961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of abnormal methionine metabolism in alcoholic liver injury.
    Lu SC; Tsukamoto H; Mato JM
    Alcohol; 2002 Jul; 27(3):155-62. PubMed ID: 12163143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective effect of S-adenosyl-l-methionine on liver damage induced by biliary obstruction in rats: a histological, ultrastructural and biochemical approach.
    Muriel P; Suarez OR; Gonzalez P; Zuñiga L
    J Hepatol; 1994 Jul; 21(1):95-102. PubMed ID: 7963428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. S-adenosyl-methionine in depression: a comprehensive review of the literature.
    Papakostas GI; Alpert JE; Fava M
    Curr Psychiatry Rep; 2003 Dec; 5(6):460-6. PubMed ID: 14609501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SAMe (S-adenosylmethionine).
    Echols JC; Naidoo U; Salzman C
    Harv Rev Psychiatry; 2000; 8(2):84-90. PubMed ID: 10902097
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of nifedipine and S-adenosylmethionine in the liver of rats treated with CCl4 and ethanol for one month.
    Cutrín C; Meniño MJ; Otero X; Míguez J; Pérez-Becerra E; Barrio E
    Life Sci; 1992; 51(10):PL113-8. PubMed ID: 1513199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Peculiarities of pharmacological correction of acute toxic hepatopathies in patients with severe forms of acute alcohol intoxication].
    Shikalova IA; Shilov VV; Batots'orenov BV; Vasil'ev SA; Loladze AT
    Klin Med (Mosk); 2012; 90(1):60-4. PubMed ID: 22567943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. S-adenosyl methionine (SAMe) augmentation in major depressive disorder.
    Nelson JC
    Am J Psychiatry; 2010 Aug; 167(8):889-91. PubMed ID: 20693465
    [No Abstract]   [Full Text] [Related]  

  • 32. [Correction of metabolic disorders during treatment of alcohol-induced liver injuries in patients with acute alcoholic intoxication].
    Shilov VV; Shikalova IA; Vasil'ev SA; Batotsyrenov BV; Andrianov AIu
    Klin Med (Mosk); 2013; 91(2):45-8. PubMed ID: 23718065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. S-Adenosylmethionine, cytokines, and alcoholic liver disease.
    McClain CJ; Hill DB; Song Z; Chawla R; Watson WH; Chen T; Barve S
    Alcohol; 2002 Jul; 27(3):185-92. PubMed ID: 12163148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. S-adenosyl-L-methionine for the treatment of chronic liver disease: a systematic review and meta-analysis.
    Guo T; Chang L; Xiao Y; Liu Q
    PLoS One; 2015; 10(3):e0122124. PubMed ID: 25774783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methionine metabolic pathway in alcoholic liver injury.
    Kharbanda KK
    Curr Opin Clin Nutr Metab Care; 2013 Jan; 16(1):89-95. PubMed ID: 23232418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Neuropsychiatric disorders and transmethylation: therapeutic effects of S-adenosyl-L-methionine].
    Agnoli A; Fazio C; Andreoli V; De Carolis V; Bonamini F; Pastorino P; Casacchia M; Cerbo R; Ruggieri S; Carolei A
    Clin Ter; 1975 Dec; 75(6):567-79. PubMed ID: 767041
    [No Abstract]   [Full Text] [Related]  

  • 37. Reversal of extrahepatic membrane cholesterol deposition in patients with chronic liver diseases by S-adenosyl-L-methionine.
    Rafique S; Guardascione M; Osman E; Burroughs AK; Owen JS
    Clin Sci (Lond); 1992 Sep; 83(3):353-6. PubMed ID: 1327655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathogenesis and treatment of alcoholic liver disease: progress over the last 50 years.
    Lieber CS
    Rocz Akad Med Bialymst; 2005; 50():7-20. PubMed ID: 16363067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hepato- and endothelioprotective action of runihol and ademetionine in experimental liver injury induced by TB drugs in combination with alcohol].
    Sukhanov DS; Artyushkova EB; Dudka VT
    Patol Fiziol Eksp Ter; 2013; (2):45-9. PubMed ID: 24000714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Characteristics of the pharmacological treatment of toxic liver damage in patients with an alcohol abused syndrome and an acute severe ethanol poison].
    Shilov VV; Shikalova IA; Vasil'ev SA; Loladze AT; Batotsyrenov BV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(1):45-8. PubMed ID: 22678675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.